REG - Spire Healthcare Grp - Director/PDMR Shareholding

Spire HealthcareAnnouncement

15/03/2024 10:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240315:nRSO0561Ha&default-theme=true

RNS Number : 0561H  Spire Healthcare Group PLC  15 March 2024

Spire Healthcare Group plc

15 March 2024

 

Notification of Transactions of Persons Discharging Managerial
Responsibilities

This notification is made in accordance with DTR 3.1.4R (1) (a) of the
Disclosure and Transparency Rules.

 

Grant of Deferred Share Bonus Plan (DSBP) Awards

Spire Healthcare Group plc (the Company) announces that on 14 March 2024,
awards (the DSBP Awards) were granted over the Company's ordinary shares in
the form of nil-cost options to the Directors named below, under the Company's
DSBP.

 

Under the DSBP, Executive Directors are required to defer a proportion of
their gross bonus, received in respect of the financial year ended 31 December
2023, into shares in the Company for a period of three years. The Directors
listed below have the following interest in shares as deferred share bonus
awards under the DSBP:

 

 Director      Percentage deferral of 2023 gross bonus*  Deferred Shares
 Justin Ash    50%                                       152,786
 Jitesh Sodha  33%                                       68,533

* To be disclosed in the 2023 Annual Report and Accounts

The share price used to determine the number of Deferred Shares subject to
award was 238.0 pence, being the mid-market closing share price on 13 March
2024 (the dealing day prior to the awards being made).

The DSBP Awards will vest on the third anniversary of the grant date on 14
March 2027.

Grant of Long Term Incentive Plan (LTIP) awards

The Company further announces that, on 14 March 2024, a performance share
award was granted over the Company's ordinary shares in the form of nil cost
options to the following Executive Directors and PDMR in the Company, under
the rules of the Company's Long Term Incentive Plan.

 

Executive Director                Maximum number of shares
under Award

Justin Ash                               542,575

 

Other PDMRs

John Forrest                            226,793

 

The number of shares set out above represents 200% of Justin Ash's base salary
and 125% of John Forrest's base salary.  It is the maximum number which may
vest under the LTIP Awards following the end of the performance period (31
December 2026).  The shareholder-approved Remuneration Policy permits awards
of up to 200% of base salary for Executive Directors.

 

The actual number of shares which vest will depend on the extent to which the
relevant performance conditions have been satisfied.

 

The performance conditions applicable to the LTIP Awards will be based as
follows:

·    20% on relative total shareholder return (TSR) performance;

·    35% on ROCE performance;

·    15% on EBITDA Margin performance; and

·    30% on two Operational Excellence measures.

 

Further details of these performance conditions will be disclosed in the 2023
Annual Report and Accounts when published.

 

The share price used to determine the number of shares under the LTIP Awards
was 237.0 pence being the average of the mid-market closing share price over
the five trading days ending on 13 March 2024.

 

The transaction place is London.

 

Notes:

 

1)   For Justin Ash the 2024 LTIP awards described above will also be
subject to a further two-year holding period following the vesting date.

2)   The actual number of shares which vest under the LTIP awards will
depend on the extent to which the relevant performance conditions are
satisfied in due course.

Name of contact and telephone number for queries:

Philip Davies

Company Secretary

Spire Healthcare Group plc

Tel:      07803 508348

 

 

Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Justin Ash

 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Deferred Share Bonus
                                                                  Plan
 c)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     Nil                                                                                                  152,786

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2024-03-14
 f)  Place of the transaction                                     XLON

 

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Jitesh Sodha

 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Deferred Share Bonus
                                                                  Plan
 c)  Price(s) and volume(s)                                       Price(s)                                Volume(s)
     Nil                                                                                                  68,533

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2024-03-14
 f)  Place of the transaction                                     XLON

 

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Justin Ash

 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Long Term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
     Nil                                                                                                    542,575

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2024-03-14
 f)  Place of the transaction                                     XLON

 

 a)  Name                                                         John Forrest

 2   Reason for the notification
 a)  Position/status                                              Chief Operating Officer/PDMR

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Long Term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
     Nil                                                                                                    226,793

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2024-03-14
 f)  Place of the transaction                                     XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBGGDXUGBDGSU